High-throughput genetic characterization of a cohort of Brugada syndrome patients.

Brugada syndrome (BrS) is an inherited cardiac arrhythmic disorder that can lead to sudden death, with a prevalence of 1:5000 in Caucasian population and affecting mainly male patients in their third to fourth decade of life. BrS is inherited as an autosomal dominant trait; however, to date genetic bases have been only partially understood. Indeed most mutations are located in the SCN5A gene, encoding the alpha-subunit of the Na(+) cardiac channel, but >70% BrS patients still remain genetically undiagnosed. Although 21 other genes have been associated with BrS susceptibility, their pathogenic role is still unclear. A recent next-generation sequencing study investigated the contribution of 45 arrhythmia susceptibility genes in BrS pathogenesis, observing a significant enrichment only for SCN5A. In our study, we evaluated the distribution of putative functional variants in a wider panel of 158 genes previously associated with arrhythmic and cardiac defects in a cohort of 91 SCN5A-negative BrS patients. In addition, to identify genes significantly enriched in BrS, we performed a mutation burden test by using as control dataset European individuals selected from the 1000Genomes project. We confirmed BrS genetic heterogeneity and identified new potential BrS candidates such as DSG2 and MYH7, suggesting a possible genetic overlap between different cardiac disorders.

[1]  M. Lazdunski,et al.  KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel , 2000, The EMBO journal.

[2]  J. Towbin,et al.  Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. , 2000, Circulation.

[3]  D. Roden.  Human genomics and its impact on arrhythmias. , 2004, Trends in cardiovascular medicine.

[4]  Wataru Shimizu,et al.  Brugada syndrome: report of the second consensus conference. , 2005, Heart rhythm.

[5]  S. Priori,et al.  Cardiac Histological Substrate in Patients With Clinical Phenotype of Brugada Syndrome , 2005, Circulation.

[6]  Yongkeun Cho,et al.  Underlying cardiomyopathy in patients with ST-segment elevation in the right precordial leads. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[7]  G. Danieli,et al.  Mutations in Desmoglein-2 Gene Are Associated With Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.

[8]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[9]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[10]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[11]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[12]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[13]  J. Towbin,et al.  An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. , 2010, Heart rhythm.

[14]  J. Hancox,et al.  KCNE5 (KCNE1L) Variants Are Novel Modulators of Brugada Syndrome and Idiopathic Ventricular Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.

[15]  D. Marchuk,et al.  Dissection of a Quantitative Trait Locus for PR Interval Duration Identifies Tnni3k as a Novel Modulator of Cardiac Conduction , 2012, PLoS genetics.

[16]  Y. Lecarpentier,et al.  Brugada ECG pattern: a physiopathological prospective study based on clinical, electrophysiological, angiographic, and genetic findings , 2012, Front. Physio..

[17]  S. Rizzo,et al.  Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. , 2012, Cardiovascular research.

[18]  C. Bezzina,et al.  Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death. , 2012, Journal of molecular and cellular cardiology.

[19]  P. Schwartz,et al.  Spectrum and Prevalence of Mutations Involving Brs1-through Brs12-susceptibility Genes in a Cohort of Unrelated Patients Referred for Brugada Syndrome Genetic Testing Implications for Genetic Testing , 2022 .

[20]  Michael J. Ackerman,et al.  A Novel Disease Gene for Brugada Syndrome: Sarcolemmal Membrane–Associated Protein Gene Mutations Impair Intracellular Trafficking of hNav1.5 , 2012, Circulation. Arrhythmia and electrophysiology.

[21]  J. Svendsen,et al.  New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants , 2013, European Journal of Human Genetics.

[22]  Morten W. Nielsen,et al.  New Exome Data Question the Pathogenicity of Genetic Variants Previously Associated With Catecholaminergic Polymorphic Ventricular Tachycardia , 2013 .

[23]  V. Probst,et al.  Molecular Genetics and Functional Anomalies in a Series of 248 Brugada Cases with 11 Mutations in the TRPM4 Channel , 2013, PloS one.

[24]  Dan M Roden,et al.  Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death , 2013, Nature Genetics.

[25]  P. Schwartz,et al.  FGF12 is a candidate Brugada syndrome locus. , 2013, Heart rhythm.

[26]  E. Behr,et al.  Genetic testing for inherited cardiac disease , 2013, Nature Reviews Cardiology.

[27]  S. Viskin,et al.  Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. , 2014, Journal of the American College of Cardiology.

[28]  S. Crump,et al.  Arrhythmogenic KCNE gene variants: current knowledge and future challenges , 2014, Front. Genet..

[29]  C. Antzelevitch,et al.  ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene. , 2014, International journal of cardiology.

[30]  K. Sampson,et al.  KCNE1 divides the voltage sensor movement in KCNQ1/KCNE1 channels into two steps , 2014, Nature Communications.

[31]  S. Priori,et al.  Missense Mutations in Plakophilin-2 Cause Sodium Current Deficit and Associate With a Brugada Syndrome Phenotype , 2014, Circulation.

[32]  M. Horie,et al.  Gain‐of‐Function KCNH2 Mutations in Patients with Brugada Syndrome , 2014, Journal of cardiovascular electrophysiology.

[33]  R. Redon,et al.  Testing the burden of rare variation in arrhythmia-susceptibility genes provides new insights into molecular diagnosis for Brugada syndrome. , 2015, Human molecular genetics.

[34]  Karen S. Frese,et al.  Atlas of the clinical genetics of human dilated cardiomyopathy. , 2014, European heart journal.